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 Antibiotic Goals 
• Promote bacteria death 
• Prevent the emergence of resistance 
• Avoid toxicity 
  
Underdosing 
 Increase in Volume of distribution 
 Increase in clearance 
Dose of Antibiotics 
  How much? 
Antibiotic must n t only attach to target but must occupy an 
adequate number of binding sites during a certain time 
That depends on drug concentration and time within the 
organism – the PK, and also on bacteria susceptibility – MIC 


















Area under the concentration curve 
MIC 
Patterns of Antimicrobial Activity 
Mainly dependent of VD 




























Vd 15-20 liters 
Vd 80-200 liters 
Vd (L)=Dose (mg) 
            Conc (mg/L) 
 The apparent volume of distribution indicates into 
how large a volume the drug distributes if it were at the 
same concentration as that in plasma 
 
 Initial peak concentration is only dependent on dose 
and volume of distribution 
 
 Clearance indicates how much fluid is cleared of the 









































Nicolau Antimicrob Agents Chemother 1995;39:650 
Baral Am J Med.2003;114:194 
Time 











Fast bactericidal activity depends on peak 
drug concentration 
Slower and independent of drug 
concentration (postantibiotic effect) 






90% probability of resolution 
by day 7 if a Cmax/MIC of ≥ 
10 is achieved within the first 
48h of aminoglycoside 
therapy  
Kashuba Antimicrob Agents Chemother 1999 

































Moore J Infect Dis 1987;155. 93 






Barza M BMJ 1996;312:338 
Meta-analysis of 21 randomised trials; N=3091  
Multiple doses or large dose 
Large dose associated with a non-significant decrease in 
antibiotics failures (especially in Pseudomonas) 
  
 
 Large dose administration reduced the risk of nephrotoxicity 
  (fixed effects risk ratio 0.74 (0.54 to 1.00)).  
 
 There was no significant difference in ototoxicity between the two 
dosing regimens, 
 but the power of the pooled trials to detect a meaningful difference was low.  
 There was no significant difference in mortality 





















Gonçalves-Pereira Clin Microbiol Infect  2010;16:1258 
Pharmacokinetics / Pharmacodynamics 
First dose of Aminoglycosides 
Taccone Crit Care 2010;14:R53 
 Amikacin 
 




7.4mg/kg. Peak target 16 mg/L 
N=32; Vd=0.41l/kg 






Vd first dose  0,41 l/kg (±0,1) 
Gonçalves-Pereira Clin Microbiol Infect  2010;16:1258 
Hilmer Br J Clin Pharmacol 2011; 71: 224–231 
R2=0.058 
R2=0.016 
Pharmacokinetics / Pharmacodynamics 









Pharmacokinetics / Pharmacodynamics 
Aminoglycosides Pharmacokinetics 
 Pharmacodynamic parameter of efficacy: Peak/MIC 







Renal proximal convoluted 












Triginer Intensive Care Med 1990;16:303-306 
Dose of antibiotics 
  Aminoglycosides 
Progressive normalization of PK 
• Normalization of the increase in Vd 
and Cl (with sepsis resolution) 
 
• High antibiotic concentration 
 
 
Use of TDM – Peak and a second measurement between 16-20h 
  Linear PK and 1st order kinetics 
480mg. Peak (1h) – 18mg/dl; Trough (17h) 2mg/dl Vd=24,1L Cl=3,3ml/min 
  Recommended dose 480mg after 28h 
  Peak (2h) – 18mg/dl; Trough (16h) 2mg/dl Vd=20,3 Cl=3,2ml/min 






Clinically evaluable patients 
(n=53) 
57% success 
































Dose of antibiotics 






To achieve therapeutic concentrations rapidly loading doses 
are recommended 
Recommend giving high end of normal loading dose (or even higher 
dose) 
– Example: Vancomycin (normal patient Vd ~0.7 L/kg) 
• 100 kg septic shock patient 
 
   Am J Health-Syst Pharm 2009;66:82-98 
Hall. Am J Med. 2008; 121: 515–518 
Dose of antibiotics 






PK monitoring – Vancomycin 
N Vd (L) Vol (L) Increase 
Vancomycin 43 75 (81) 49 53.1% 
 DALI Data 
As presented in the 25th ESICM Congress 
N Cl (L/H) Vol (L/H) Increase Cr Cl (L/H) RRT 





Trough 58% (Css>20) 42% (>15) 
AUC/MIC>400 88% 45% 






Therapeutic Drug Monitoring 
Vancomycin – Bolus dosing  
Measured concentrations were more often in therapeutic range when guided by 
TDM then by Moellering’s nomogram. 
 Out of Therapeutic Range 
   Peak  A-50% B-50% 
  Trough  A-0% B-43.8%  
  Dose/kg A – 19±0.5 mg B – 17±0.4 mg 













Baptista Int J Antimicrob Agents 2012;39:420 
20ug/mL 
Cl Cr>130mL/min 
        Vs. 
Cl Cr<130mL/min 
Vancomycin continuous infusion 
 
Cl vanco (L/h) = 0.021 x ClCr (8h) (mL/m) + 2.3 
 
Perfusion Rate vanco (g/d) = Cl Vanco x 0,6 
 
                       Baptista ESICM 2013 
 
Dose of antibiotics 
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Standard dose of vancomycin (n=220) 
High dose of vancomycin (n=26) 




Standard (<4 g/day)  9 
High (≥4 g/day)  18 
Time to nephrotoxicity for patients treated with vancomycin 









































Recommended dosing regimens in MODS 






Approach to Dose during Hemofiltration 


























An expert is someone who has stop 
thinking. He knows… 
  Frank Lloyd Wright  
